These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8911510)

  • 1. Association of radionuclide bone scan and serum alkaline phosphatase in patients with metastatic renal cell carcinoma.
    Seaman E; Goluboff ET; Ross S; Sawczuk IS
    Urology; 1996 Nov; 48(5):692-5. PubMed ID: 8911510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal alkaline phosphatase levels in patients with bone metastases due to renal cell carcinoma.
    Kriteman L; Sanders WH
    Urology; 1998 Mar; 51(3):397-9. PubMed ID: 9510341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of serum alkaline phosphatase and radionuclide bone scans in patients with renal cell carcinoma.
    Atlas I; Kwan D; Stone N
    Urology; 1991 Sep; 38(3):220-2. PubMed ID: 1887534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre.
    Ruatta F; Derosa L; Escudier B; Colomba E; Guida A; Baciarello G; Loriot Y; Fizazi K; Albiges L
    Eur J Cancer; 2019 Jan; 107():79-85. PubMed ID: 30551078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eastern Cooperative Oncology Group performance status predicts bone metastasis in patients presenting with renal cell carcinoma: implication for preoperative bone scans.
    Shvarts O; Lam JS; Kim HL; Han KR; Figlin R; Belldegrun A
    J Urol; 2004 Sep; 172(3):867-70. PubMed ID: 15310985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers.
    Mani S; Todd MB; Katz K; Poo WJ
    J Urol; 1995 Jul; 154(1):35-40. PubMed ID: 7539867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of bone scan in patients with renal cell carcinoma.
    Koga S; Tsuda S; Nishikido M; Ogawa Y; Hayashi K; Hayashi T; Kanetake H
    J Urol; 2001 Dec; 166(6):2126-8. PubMed ID: 11696720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum gamma glutamyl-transferase is a sensitive but unspecific marker of metastatic renal cell carcinoma.
    Simic T; Dragicevic D; Savic-Radojevic A; Cimbaljevic S; Tulic C; Mimic-Oka J
    Int J Urol; 2007 Apr; 14(4):289-93. PubMed ID: 17470155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of osseous metastases in patients with renal cell carcinoma.
    Jung ST; Ghert MA; Harrelson JM; Scully SP
    Clin Orthop Relat Res; 2003 Apr; (409):223-31. PubMed ID: 12671506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone metastasis secondary to renal carcinoma diagnosed with bone scintigraphy].
    Ruiz Hernández G; Ferrer Albiach C; Balaguer Martínez JV; Romero de Avila C; Castillo Pallarés FJ
    Actas Urol Esp; 2001 Oct; 25(9):679-82. PubMed ID: 11765556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma.
    Ramankulov A; Lein M; Kristiansen G; Meyer HA; Loening SA; Jung K
    J Cancer Res Clin Oncol; 2007 Sep; 133(9):643-52. PubMed ID: 17479289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a diagnostic role for bone scanning of patients with a high pretest probability for metastatic renal cell carcinoma?
    Staudenherz A; Steiner B; Puig S; Kainberger F; Leitha T
    Cancer; 1999 Jan; 85(1):153-5. PubMed ID: 9921987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient survival after surgery for osseous metastases from renal cell carcinoma.
    Lin PP; Mirza AN; Lewis VO; Cannon CP; Tu SM; Tannir NM; Yasko AW
    J Bone Joint Surg Am; 2007 Aug; 89(8):1794-801. PubMed ID: 17671020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic elevation of serum alkaline phosphatase in renal cell carcinoma: incidence and implication on prognosis.
    Chuang YC; Lin AT; Chen KK; Chang YH; Chen MT; Chang LS
    J Urol; 1997 Nov; 158(5):1684-7. PubMed ID: 9334578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of gamma-glutamyl transpeptidase in the preoperative metastatic evaluation of renal cell carcinoma.
    Sandock DS; Seftel AD; Resnick MI
    J Urol; 1997 Mar; 157(3):798-9. PubMed ID: 9072569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant radiotherapy and transarterial chemoembolization reduce skeletal-related events related to bone metastases from renal cell carcinoma.
    Heianna J; Makino W; Ariga T; Ishikawa K; Kusada T; Maemoto H; Toguchi M; Ito J; Goya M; Miyazato M; Iraha Y; Murayama S
    Eur Radiol; 2020 Mar; 30(3):1525-1533. PubMed ID: 31728686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massive endoprosthetic replacement for bone metastases resulting from renal cell carcinoma: factors influencing patient survival.
    Hwang N; Nandra R; Grimer RJ; Carter SR; Tillman RM; Abudu A; Jeys LM
    Eur J Surg Oncol; 2014 Apr; 40(4):429-34. PubMed ID: 24063967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of bone-specific alkaline phosphatase for bone metastases detection in prostate cancer].
    Rasch-Isla Muñoz A; Cataño Cataño JG
    Arch Esp Urol; 2004 Sep; 57(7):693-8. PubMed ID: 15536950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of bone metastases from renal cell carcinoma].
    Hoshi S; Orikasa S; Yoshikawa K; Metoki R; Tochigi T; Ono K; Saitoh S; Satoh M; Ohyama C; Suzuki K
    Nihon Hinyokika Gakkai Zasshi; 1991 Apr; 82(4):649-54. PubMed ID: 2051704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of procollagen type 1 amino-terminal propeptide in patients with renal cell carcinoma.
    Klepzig M; Sauer-Eppel H; Jonas D; Oremek GM
    Anticancer Res; 2008; 28(4C):2443-6. PubMed ID: 18751432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.